Skip to main content
30 April 2021 News
This article is available in: English

CliniSys Group creates single brand for UK and Europe

New identity for CliniSys | MIPS and MIPS is launched with refreshed logo and updated website

Move reflects 40-year history of delivering industry-leading, end-to-end solutions for customers paired with a commitment to future innovation  

CliniSys Group has created a single brand for its businesses in the UK and Europe, with a refreshed logo and a new website.

The move creates a unified identity for CliniSys | MIPS in the UK and MIPS on the continent and underlines the group’s commitment to providing end-to-end diagnostic systems to support safe and effective healthcare systems today and to drive medical innovation in the future.

Chair and chief executive Michael Simpson said: “The CliniSys Group is the largest diagnostic laboratory IT vendor in Europe. Our combined cross-discipline expertise, spanning more than 40 years, provides our customers with solutions that span the diagnostic journey.

“We have reached this position by following our core values: customer, promises, simplicity and teamwork – a commitment to providing customers with the best possible products, services and support. From late March, we have a new look but our values remain steadfast, and we look forward to continuing to care for our customers while working with them on the innovative solutions that we will all need for the future.”

In Europe, CliniSys | MIPS will be the new brand name for MIPS, which is best known for its high-performance laboratory information management system, GLIMS. This is the most widely used LIS on the continent, where it is relied on by 25.000 people operating in 19 countries and ten languages.

MIPS also has a history of innovation. It has developed GLIMS Genetics as an add-on to GLIMS to meet the needs of new, high-tech genetics laboratories, and seen it successfully deployed in Poitiers University Hospital.

John Lebon, CliniSys | MIPS chief executive, said: “First things first, our commitment to our customers remains our focus.
MIPS has been part of the CliniSys | MIPS group for over 15 years, and with the refresh of our branding we are now positioning ourselves as CliniSys | MIPS, underpinning the international presence of our group and the strength of our combined solutions to support laboratory workflow across clinical, histology, molecular, genetics, anatomical pathology, including order management, reporting and results delivery. Recently, GLIMS Genetics has been brought to the UK, which is developing its own network of genetic laboratory hubs.”

In the UK, CliniSys | MIPS is best-known for its development of laboratory information systems. In October 2015, it was acquired by Roper Technologies and this has enabled it to add systems from complementary suppliers, such as Sunquest Information Systems and Data Innovations.

This has enabled CliniSys | MIPS to offer its UK customers industry-leading, end-to-end solutions, and to think creatively about meeting the needs of pathology networks, integrated care systems, and the coming world of precision medicine.

The CliniSys | MIPS name is being retained in the UK, although the logo has been refreshed.

Alongside its new identity, CliniSys | MIPS has launched a new website with information about its products, case studies highlighting the great work being done by its customers, and blogs about the development of pathology and diagnostic laboratory IT.

There are no changes to the group’s contracts, support services, product roadmap or release schedule.